TELEFLEX INCORPORATED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
TELEFLEX INCORPORATED (TFX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$2.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-08-06
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-06-30 was -$67.00K, a 100.42% decline year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-03-31 was -$2.63M.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was $371.00K, a 85.63% decline year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-28 was $2.00M, a 25.16% increase year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was $16.45M, a 64.02% increase from fiscal 2024.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was $10.03M.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was -$27.24M, a 1259.28% decline from fiscal 2022.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was $2.35M, a 51.99% decline from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.70M 10-Q · filed 2026-08-06 | -$2.33M derived: sum of 3 quarters · filed 2026-08-06 | -$333.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$2.63M 10-Q · filed 2026-05-07 | -$2.26M derived: sum of 2 quarters · filed 2026-05-07 | -$266.00K derived: sum of 3 quarters · filed 2026-05-07 | $15.61M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-12-31 | $371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.37M derived: sum of 2 quarters · filed 2026-02-27 | $18.24M derived: sum of 3 quarters · filed 2026-02-27 | $16.45M 10-K · filed 2026-02-27 | |
| 2025-09-28 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.87M derived: sum of 2 quarters · filed 2025-11-06 | $16.07M 10-Q · filed 2025-11-06 | $18.66M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2025-06-29 | $15.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $14.08M 10-Q · filed 2025-07-31 | $16.66M derived: sum of 3 quarters · filed 2026-02-27 | $18.25M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2025-03-30 | -$1.79M 10-Q · filed 2025-05-01 | $786.00K derived: sum of 2 quarters · filed 2026-02-27 | $2.38M derived: sum of 3 quarters · filed 2026-02-27 | $7.37M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.17M derived: sum of 2 quarters · filed 2026-02-27 | $9.16M derived: sum of 3 quarters · filed 2026-02-27 | $10.03M 10-K · filed 2026-02-27 | |
| 2024-09-29 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $6.58M derived: sum of 2 quarters · filed 2024-10-31 | $7.45M 10-Q · filed 2024-10-31 | $4.68M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2024-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $5.85M 10-Q · filed 2024-08-02 | $3.09M derived: sum of 3 quarters · filed 2025-02-28 | -$14.62M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2024-03-31 | $865.00K 10-Q · filed 2024-05-03 | -$1.90M derived: sum of 2 quarters · filed 2025-02-28 | -$19.60M derived: sum of 3 quarters · filed 2025-02-28 | -$28.82M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-12-31 | -$2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$20.47M derived: sum of 2 quarters · filed 2025-02-28 | -$29.69M derived: sum of 3 quarters · filed 2025-02-28 | -$27.24M 10-K · filed 2025-02-28 | |
| 2023-10-01 | -$17.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$26.93M derived: sum of 2 quarters · filed 2023-11-03 | -$24.48M 10-Q · filed 2023-11-03 | ||
| 2023-07-02 | -$9.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$6.78M 10-Q · filed 2023-08-03 | |||
| 2023-04-02 | $2.45M 10-Q · filed 2023-05-04 | ||||
| 2022-12-31 | $2.35M 10-K · filed 2024-02-23 | ||||
| 2021-12-31 | $14.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $12.74M derived: sum of 2 quarters · filed 2023-02-23 | $11.25M derived: sum of 3 quarters · filed 2023-02-23 | $4.89M 10-K · filed 2023-02-23 | |
| 2021-09-26 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$2.79M derived: sum of 2 quarters · filed 2021-10-28 | -$9.15M 10-Q · filed 2021-10-28 | ||
| 2021-06-27 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$7.85M 10-Q · filed 2021-07-29 | |||
| 2021-03-28 | -$6.35M 10-Q · filed 2021-04-29 | ||||
| 2020-12-31 | -$36.71M 10-K · filed 2022-03-01 | $36.71M 10-K · filed 2021-02-25 | |||
| 2019-12-31 | -$53.91M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |